|
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid |
|
CHEBI:64210 |
|
An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARα agonist. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-15(7-10-17(18)21)19(24)23-16-8-5-14(6-9-16)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) |
SZWKGOZKRMMLAJ-UHFFFAOYSA-N |
CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
retinoic acid receptor alpha/beta agonist
Any retinoic acid receptor (RAR) agonist with specificity for RARalpha and RARbeta.
|
|
retinoic acid receptor alpha/beta agonist
Any retinoic acid receptor (RAR) agonist with specificity for RARalpha and RARbeta.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
Outgoing
|
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid
(CHEBI:64210)
has role
antineoplastic agent
(CHEBI:35610)
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid
(CHEBI:64210)
has role
retinoic acid receptor α/β agonist
(CHEBI:50741)
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid
(CHEBI:64210)
is a
amidobenzoic acid
(CHEBI:48470)
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid
(CHEBI:64210)
is a
tetralins
(CHEBI:36786)
|
|
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid
|
Am 580
|
ChemIDplus
|
AM-580
|
ChemIDplus
|
AM580
|
ChEBI
|
CD 336
|
ChemIDplus
|
CD-336
|
ChemIDplus
|
102121-60-8
|
CAS Registry Number
|
KEGG COMPOUND
|
102121-60-8
|
CAS Registry Number
|
ChemIDplus
|
3565084
|
Reaxys Registry Number
|
Reaxys
|
18271925
|
PubMed citation
|
Europe PMC
|
18416830
|
PubMed citation
|
Europe PMC
|
19700416
|
PubMed citation
|
Europe PMC
|
19790202
|
PubMed citation
|
Europe PMC
|
20147703
|
PubMed citation
|
Europe PMC
|
20453882
|
PubMed citation
|
Europe PMC
|
21150871
|
PubMed citation
|
Europe PMC
|
21310893
|
PubMed citation
|
Europe PMC
|
21715427
|
PubMed citation
|
Europe PMC
|
22258322
|
PubMed citation
|
Europe PMC
|
22353356
|
PubMed citation
|
Europe PMC
|
|